← Back to Search

Other

Citicoline for Bipolar Disorder

Phase 4
Waitlist Available
Research Sponsored by Sherwood Brown, MD, PhD
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 weeks
Awards & highlights

Summary

This trial tests citicoline and pregnenolone in people with alcohol use disorder and bipolar or schizoaffective disorder. These treatments aim to improve brain function, reduce alcohol cravings, and stabilize mood. Citicoline modulates phospholipids metabolism and neurotransmitter levels and appears to improve cognition in some central nervous system disorders.

Eligible Conditions
  • Bipolar Disorder
  • Bipolar disorder
  • Alcoholism

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 weeks for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Drinks per Drinking Day (TLFB)

Side effects data

From 2016 Phase 4 trial • 62 Patients • NCT02074735
17%
Drowsiness
14%
Dry mouth
14%
Nausea
10%
Diarrhea
7%
Headache
3%
Increased energy
3%
Bruising
3%
Hypertension
3%
Rash
100%
80%
60%
40%
20%
0%
Study treatment Arm
Placebo
Citicoline

Trial Design

3Treatment groups
Experimental Treatment
Placebo Group
Group I: PregnenoloneExperimental Treatment1 Intervention
Pregnenolone will be given beginning at 50 mg BID with an increase to 100 mg BID at week 1, 150 mg BID at week 2, and 250 mg BID at weeks 3-12.
Group II: CiticolineExperimental Treatment1 Intervention
Citicoline will be given beginning at 250 mg BID with an increase to 500 mg BID at week 1, 750 mg BID at week 2, and 1000 mg BID at weeks 3-12.
Group III: PlaceboPlacebo Group1 Intervention
Matching placebo given beginning at 1 capsule twice daily (BID) increasing to 2 capsules BID at week 1, 3 capsules BID at week 2, and 4 capsules BID at weeks 3-12.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Pregnenolone
2011
Completed Phase 4
~770
Citicoline
2010
Completed Phase 4
~780

Find a Location

Who is running the clinical trial?

University of Texas Rio Grande ValleyOTHER
7 Previous Clinical Trials
2,579 Total Patients Enrolled
Sherwood Brown, MD, PhDLead Sponsor
University of MiamiOTHER
935 Previous Clinical Trials
422,121 Total Patients Enrolled
4 Trials studying Bipolar Disorder
280 Patients Enrolled for Bipolar Disorder
~10 spots leftby Sep 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top